Pharmaceutical Ingredients Telmisartan 144701-48-4 99% Purity Telmisartan Antihypertensive Telmisart

Category:Intermediates > Pharmaceutical Intermediates
Product Name:Pharmaceutical Ingredients Telmisartan 144701-48-4 99% Purity Telmisartan Antihypertensive Telmisart
CAS No.:144701-48-4
Standard:In-house Standards
Price(USD):US$400~US$2000/Kg
Company:SCM Pioneering Co.,Ltd

Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: Shandong, China

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Monthly Production Capacity: 1000kg

    Contract Manufacturing: CRO,CMO

    Packaging Information: 10kg/barrel

  • Delivery Lead Time: 7-50days

    Sample Provided: yes

    Payment Terms: T/T

    Product Details

    Product name Telmisartan
    Purity 99%
    Appearance White Crystalline powder
    CAS NO 144701-48-4
    Molecular Formula C33H30N4O2
    Shelf life 2 years

    Telmisartan tablets, hypertension for the treatment of essential hypertension in adults. Reduce cardiovascular risk. This product is suitable for age 55 and above. To reduce the incidence of myocardial infarction in patients who are at high risk for serious cardiovascular events and cannot be treated with ACE inhibitors. Risk of death from stroke or cardiovascular disease. The high risk of cardiovascular events includes coronary artery disease. History of high-risk type 2 diabetes (insulin-dependent or non-insulin-dependent) with peripheral artery disease, stroke, transient ischemic attack, or evidence of end-organ damage. Telmisartan can also be used in conjunction with other necessary treatments (such as blood pressure medications). Antiplatelet agents or lipid-lowering agents).

    Application&Function

    Telmisartan tablets, hypertension for the treatment of essential hypertension in adults. Reduce cardiovascular risk. This product is suitable for age 55 and above. To reduce the incidence of myocardial infarction in patients who are at high risk for serious cardiovascular events and cannot be treated with ACE inhibitors. Risk of death from stroke or cardiovascular disease. The high risk of cardiovascular events includes coronary artery disease. History of high-risk type 2 diabetes (insulin-dependent or non-insulin-dependent) with peripheral artery disease, stroke, transient ischemic attack, or evidence of end-organ damage. Telmisartan can also be used in conjunction with other necessary treatments (such as blood pressure medications). Antiplatelet agents or lipid-lowering agents).

Send your message to this supplier
  • From:
  • To:
    SCM Pioneering Co.,Ltd
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service